Unicycive Therapeutics, Inc.
Ticker: 1766140
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY23 | Q1 FY23 | Q3 FY22 | Q3 FY22 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.68+0.0% | 0.68-28.4% | 0.95+0.0% | 0.95 |
| Total Income | 0.68+0.0% | 0.68-28.4% | 0.95+0.0% | 0.95 |
| EXPENSES | ||||
| Expenditure | 15.25+212.5% | 4.88-25.0% | 6.51+0.0% | 6.51 |
| PROFIT | ||||
| Net Profit | -14.58+0.0% | -14.58-162.2% | -5.56+0.0% | -5.56 |
| KEY METRICS | ||||
| OPM % | — | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.97+0.0% | -0.97-162.2% | -0.37+0.0% | -0.37 |
Corporate Events
Board MeetingUNCY
20261Oct
Board Meeting
Appointment of Meredith S. Manning as an independent directo…
SEC Filing ↗ Board MeetingUNCY
202619Jun
Board Meeting
Annual Meeting of Stockholders to elect directors and ratify…
SEC Filing ↗ Board MeetingUNCY
20266Apr
Board Meeting
Director Resignation — Gaurav Aggarwal resigned from the Boa…
SEC Filing ↗